-
1 Comment
Hubei Guangji Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.3% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Hubei Guangji Pharmaceutical Co., Ltd's total revenue sank by 0.4% to $175M since the same quarter in the previous year.
Its net income has increased by 255.5% to $27M since the same quarter in the previous year.
Finally, its free cash flow grew by 99.2% to $-207K since the same quarter in the previous year.
Based on the above factors, Hubei Guangji Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE0000010R5 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| PE Ratio | None |
|---|---|
| Market Cap | 2B |
| Target Price | 40 |
| Beta | 0.19 |
| Dividend Yield | None |
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China. The company also exports its products to approximately 30 countries and regions worldwide. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000952.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
